Miner, Martin and Nehra, Ajay and Jackson, Graham and Bhasin, Shalender and Billups, Kevin and Burnett, Arthur L and Buvat, Jacques and Carson, Culley and Cunningham, Glenn and Ganz, Peter and Goldstein, Irwin and Guay, Andre and Hackett, Geoff and Kloner, Robert A and Kostis, John B and LaFlamme, K Elizabeth and Montorsi, Piero and Ramsey, Melinda and Rosen, Raymond and Sadovsky, Richard and Seftel, Allen and Shabsigh, Ridwan and Vlachopoulos, Charalambos and Wu, Frederick (2014) All men with vasculogenic erectile dysfunction require a cardiovascular workup. The American journal of medicine, 127 (3). pp. 174-82. ISSN 1555-7162. This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their Athens login IDsFull text not available from this repository.
An association between erectile dysfunction and cardiovascular disease has long been recognized, and studies suggest that erectile dysfunction is an independent marker of cardiovascular disease risk. Therefore, assessment and management of erectile dysfunction may help identify and reduce the risk of future cardiovascular events, particularly in younger men. The initial erectile dysfunction evaluation should distinguish between predominantly vasculogenic erectile dysfunction and erectile dysfunction of other etiologies. For men believed to have predominantly vasculogenic erectile dysfunction, we recommend that initial cardiovascular risk stratification be based on the Framingham Risk Score. Management of men with erectile dysfunction who are at low risk for cardiovascular disease should focus on risk-factor control; men at high risk, including those with cardiovascular symptoms, should be referred to a cardiologist. Intermediate-risk men should undergo noninvasive evaluation for subclinical atherosclerosis. A growing body of evidence supports the use of emerging prognostic markers to further understand cardiovascular risk in men with erectile dysfunction, but few markers have been prospectively evaluated in this population. In conclusion, we support cardiovascular risk stratification and risk-factor management in all men with vasculogenic erectile dysfunction.
|Additional Information:||This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their Athens login IDs|
|Subjects:||WJ Urogenital system. Urology|
|Divisions:||Planned IP Care > Urology|
|Depositing User:||Mrs Yolande Brookes|
|Date Deposited:||18 Aug 2014 15:03|
|Last Modified:||18 Aug 2014 15:03|
Actions (login required)